goralatide has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hrenak, J; Paulis, L; Simko, F | 1 |
1 review(s) available for goralatide and Cardiovascular Diseases
| Article | Year |
|---|---|
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Cardiovascular Diseases; Cardiovascular System; Humans; Kidney; Molecular Targeted Therapy; Oligopeptides; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2015 |